You are viewing the site in preview mode
Skip to main content
|
Characteristic
|
SNP (n = 8)
|
PLHIV (n = 8)
|
p-value
|
|---|
|
Age in years, mean (SD)
|
28.84 (8.11)
|
36.61 (9.44)
|
0.10
|
|
Female sex, n (%)
|
6 (75)
|
4 (50)
|
0.30
|
|
Height (m), mean (SD)
|
1.59 (0.09)
|
1.64 (0.08)
|
0.20
|
|
Weight (kg), mean (SD)
|
49.51 (11.24)
|
57.23 (9.99)
|
0.17
|
|
BMI (kg/m2), mean (SD)
|
19.54 (3.03)
|
21.19 (3.50)
|
0.33
|
|
Leg length (cm), mean (SD)
|
84.72 (5.52)
|
85.86 (4.40)
|
0.65
|
|
Most recent CD4+ T-cell count (cells/µL), mean (SD)
|
–
|
558.25 (181.80)
|
–
|
|
Detectable viral load (> 50 cp/mL), n (%)
|
–
|
6 (75)
|
–
|
|
Years since HIV diagnosis, n (%)
|
–
| | |
|
< 2 years
|
–
|
4 (50)
|
–
|
|
2–5 years
|
–
|
2 (25)
|
–
|
|
5–15 years
|
–
|
1 (12.5)
|
–
|
|
> 15 years
|
–
|
1 (12.5)
|
–
|
|
On ART, n (%)
|
–
|
6 (75)
|
–
|
|
ART duration in weeks, median (IQR)
|
–
|
71.50 (16.00–465.00)
|
–
|
- BMI body mass index, ART antiretroviral therapy, PLHIV people living with HIV-1 infection, SNP HIV-seronegative participants
